Summary of the Genetics of Obsessive-Compulsive Disorder Proceedings of the Third IOCDC
暂无分享,去创建一个
C. Pato | M. Pato | J. Kennedy | D. Pauls | J. Kennedy
[1] C. Pato,et al. The genetics of obsessive-compulsive disorder , 2001, Current psychiatry reports.
[2] J. Riskind,et al. Obsessive-Compulsive Disorder: Theory, Research, and Treatment , 1999, Journal of Cognitive Psychotherapy.
[3] J. Ott,et al. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] K. Lesch,et al. Systematic screening for mutations in the coding region of the human serotonin transporter (5-HTT) gene using PCR and DGGE. , 1996, American journal of medical genetics.
[5] D. Murphy,et al. Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. , 1996, American journal of medical genetics.
[6] S. Cichon,et al. Association study of a null mutation in the dopamine D4 receptor gene in Italian patients with obsessive‐compulsive disorder, bipolar mood disorder and schizophrenia , 1996, Psychiatric genetics.
[7] E. Smeraldi,et al. Complex segregation analysis of obsessive compulsive and spectrum related disorders: 22.3 , 1995 .
[8] W. Goodman,et al. A family study of obsessive-compulsive disorder. , 1995, The American journal of psychiatry.
[9] C. McDougle,et al. The role of central oxytocin in obsessive compulsive disorder and related normal behavior , 1994, Psychoneuroendocrinology.
[10] C. McDougle,et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. , 1994, Archives of general psychiatry.
[11] C. McDougle,et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. , 1994, Archives of general psychiatry.
[12] C. McDougle,et al. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder. , 1993, Journal of clinical psychopharmacology.
[13] H. Westenberg,et al. Oxytocin in obsessive compulsive disorder , 1992, Peptides.
[14] J. Rapoport,et al. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. , 1992, The American journal of psychiatry.
[15] E. Smeraldi,et al. Psychiatric disorders in the families of patients with obsessive-compulsive disorder , 1992, Psychiatry Research.
[16] R. Hoehn-Saric,et al. A family study of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.
[17] D. Murphy,et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. , 1992, Archives of general psychiatry.
[18] J. McCracken,et al. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine. , 1991, Journal of the American Academy of Child and Adolescent Psychiatry.
[19] J. Rapoport,et al. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.
[20] C. McDougle,et al. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder? , 1990, The Journal of clinical psychiatry.
[21] T. Insel,et al. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology , 1987, Biological Psychiatry.